Argus
•
Dec 30, 2025
Amgen Inc.: Raising price target to $360
Symbols
Sector(s)
Rating
Earnings Estimate
Current Price
Price Target
Summary
Amgen, based in Thousand Oaks, California, is a leading global biotech company. Its key products include Prolia, Enbrel, Otezla, Repatha, Xgeva, Tepezza, Evenity, Blincyto, Kyprolis, Kry
https://finance.yahoo.com/research/reports/ARGUS_2708_AnalystReport_1767096346000/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.